556 related articles for article (PubMed ID: 26119820)
1. Reactive oxygen species derived from xanthine oxidase interrupt dimerization of breast cancer resistance protein, resulting in suppression of uric acid excretion to the intestinal lumen.
Ogura J; Kuwayama K; Sasaki S; Kaneko C; Koizumi T; Yabe K; Tsujimoto T; Takeno R; Takaya A; Kobayashi M; Yamaguchi H; Iseki K
Biochem Pharmacol; 2015 Sep; 97(1):89-98. PubMed ID: 26119820
[TBL] [Abstract][Full Text] [Related]
2. Fructose suppresses uric acid excretion to the intestinal lumen as a result of the induction of oxidative stress by NADPH oxidase activation.
Kaneko C; Ogura J; Sasaki S; Okamoto K; Kobayashi M; Kuwayama K; Narumi K; Iseki K
Biochim Biophys Acta Gen Subj; 2017 Mar; 1861(3):559-566. PubMed ID: 27913188
[TBL] [Abstract][Full Text] [Related]
3. Intestinal ischemia-reperfusion increases efflux for uric acid via paracellular route in the intestine, but decreases that via transcellular route mediated by BCRP.
Ogura J; Kuwayama K; Takaya A; Terada Y; Tsujimoto T; Koizumi T; Maruyama H; Fujikawa A; Takahashi N; Kobayashi M; Itagaki S; Hirano T; Yamaguchi H; Iseki K
J Pharm Pharm Sci; 2012; 15(2):295-304. PubMed ID: 22579008
[TBL] [Abstract][Full Text] [Related]
4. Hyperuricemia enhances intracellular urate accumulation via down-regulation of cell-surface BCRP/ABCG2 expression in vascular endothelial cells.
Komori H; Yamada K; Tamai I
Biochim Biophys Acta Biomembr; 2018 May; 1860(5):973-980. PubMed ID: 29317200
[TBL] [Abstract][Full Text] [Related]
5. 3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout.
Lü JM; Yao Q; Chen C
Biochem Pharmacol; 2013 Nov; 86(9):1328-37. PubMed ID: 23994369
[TBL] [Abstract][Full Text] [Related]
6. Longan seed extract reduces hyperuricemia via modulating urate transporters and suppressing xanthine oxidase activity.
Hou CW; Lee YC; Hung HF; Fu HW; Jeng KC
Am J Chin Med; 2012; 40(5):979-91. PubMed ID: 22928829
[TBL] [Abstract][Full Text] [Related]
7. Extra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2.
Hosomi A; Nakanishi T; Fujita T; Tamai I
PLoS One; 2012; 7(2):e30456. PubMed ID: 22348008
[TBL] [Abstract][Full Text] [Related]
8. Hyperuricemia influences tryptophan metabolism via inhibition of multidrug resistance protein 4 (MRP4) and breast cancer resistance protein (BCRP).
Dankers AC; Mutsaers HA; Dijkman HB; van den Heuvel LP; Hoenderop JG; Sweep FC; Russel FG; Masereeuw R
Biochim Biophys Acta; 2013 Oct; 1832(10):1715-22. PubMed ID: 23665398
[TBL] [Abstract][Full Text] [Related]
9. Xanthine oxidase inhibition attenuates skeletal muscle signaling following acute exercise but does not impair mitochondrial adaptations to endurance training.
Wadley GD; Nicolas MA; Hiam DS; McConell GK
Am J Physiol Endocrinol Metab; 2013 Apr; 304(8):E853-62. PubMed ID: 23462817
[TBL] [Abstract][Full Text] [Related]
10. Electrochemical analysis of uric acid excretion to the intestinal lumen: Effect of serum uric acid-lowering drugs and 5/6 nephrectomy on intestinal uric acid levels.
Fujita K; Yamada H; Iijima M; Ichida K
PLoS One; 2019; 14(12):e0226918. PubMed ID: 31891613
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response.
Wen CC; Yee SW; Liang X; Hoffmann TJ; Kvale MN; Banda Y; Jorgenson E; Schaefer C; Risch N; Giacomini KM
Clin Pharmacol Ther; 2015 May; 97(5):518-25. PubMed ID: 25676789
[TBL] [Abstract][Full Text] [Related]
12. [Xanthine dehydrogenase (xanthine oxidase)].
Ichida K; Yamaguchi Y; Matsumura T
Nihon Rinsho; 2003 Jan; 61 Suppl 1():98-102. PubMed ID: 12629699
[No Abstract] [Full Text] [Related]
13. Green tea polyphenols decreases uric acid level through xanthine oxidase and renal urate transporters in hyperuricemic mice.
Chen G; Tan ML; Li KK; Leung PC; Ko CH
J Ethnopharmacol; 2015 Dec; 175():14-20. PubMed ID: 26344851
[TBL] [Abstract][Full Text] [Related]
14. Lithospermic acid as a novel xanthine oxidase inhibitor has anti-inflammatory and hypouricemic effects in rats.
Liu X; Chen R; Shang Y; Jiao B; Huang C
Chem Biol Interact; 2008 Nov; 176(2-3):137-42. PubMed ID: 18694741
[TBL] [Abstract][Full Text] [Related]
15. Flavonoids and phenylethanoid glycosides from Lippia nodiflora as promising antihyperuricemic agents and elucidation of their mechanism of action.
Cheng LC; Murugaiyah V; Chan KL
J Ethnopharmacol; 2015 Dec; 176():485-93. PubMed ID: 26593216
[TBL] [Abstract][Full Text] [Related]
16. Xanthine oxidase inhibitors from the leaves of Lagerstroemia speciosa (L.) Pers.
Unno T; Sugimoto A; Kakuda T
J Ethnopharmacol; 2004 Aug; 93(2-3):391-5. PubMed ID: 15234783
[TBL] [Abstract][Full Text] [Related]
17. Xanthine oxidase inhibitory activity and antihyperuricemic effect of Moringa oleifera Lam. leaf hydrolysate rich in phenolics and peptides.
Tian Y; Lin L; Zhao M; Peng A; Zhao K
J Ethnopharmacol; 2021 Apr; 270():113808. PubMed ID: 33450289
[TBL] [Abstract][Full Text] [Related]
18. Allopurinol decreases serum uric acid level and intestinal glucose transporter-5 expression in rats with fructose-induced hyperuricemia.
Chen G; Jia P
Pharmacol Rep; 2016 Aug; 68(4):782-6. PubMed ID: 27258609
[TBL] [Abstract][Full Text] [Related]
19. Uricosuric drugs: the once and future therapy for hyperuricemia?
Bach MH; Simkin PA
Curr Opin Rheumatol; 2014 Mar; 26(2):169-75. PubMed ID: 24445479
[TBL] [Abstract][Full Text] [Related]
20. Bisphenol A promotes hyperuricemia via activating xanthine oxidase.
Ma L; Hu J; Li J; Yang Y; Zhang L; Zou L; Gao R; Peng C; Wang Y; Luo T; Xiang X; Qing H; Xiao X; Wu C; Wang Z; He JC; Li Q; Yang S
FASEB J; 2018 Feb; 32(2):1007-1016. PubMed ID: 29042453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
